-
Watson's revenue grows 25%
SAN FRANCISCO — Though it plans to announce its fiscal year 2010 results next month, Watson Pharmaceuticals offered a peak at some preliminary numbers at the 29th annual J.P. Morgan Healthcare Conference Wednesday.
Watson said that based on a review of results for last year, it expects to have earned revenues of more than $3.5 billion, a 25% increase over 2009.
-
Canadian analyst speculates on Katz Group sale
MISSISSAUGA, Ontario — Katz Group Canada is withholding comment on a report in the Edmonton Journal Wednesday that speculated on the potential sale of the Canadian drug store giant.
“Katz Group does not comment on rumors or speculation,” said company spokeswoman Michelle Lee when asked about the report.